Ed Susman


ECCO: Circulating Tumor Cells May Aid in Breast Cancer Prognosis

September 26, 2007

BARCELONA -- Monitoring circulating tumor cells in women with breast cancer may be help guide treatment and refine prognoses, according to preliminary data from German investigators.

DOD PROSTATE: Prostate Cancer Patients Should Heed Cardiovascular Risk Factors

September 12, 2007

ATLANTA -- A prostate cancer diagnosis should be a cardiovascular wake-up call, said researchers here.

APSS: New drugs for insomnia will focus on safety

June 14, 2007

MINNEAPOLIS, Minn. -- Sleep specialists here reviewed the problems and alternatives for treating insomnia.

APSS: Short-Wave Sleep Enhancers May Have Roll in Insomnia

June 13, 2007

MINNEAPOLIS, Minn. -- Despite disappointing performance in clinical trials, anti-insomnia drugs that improve short-wave sleep may still have a role in helping people get a good night's rest, a specialist predicted here.

ACC: Early Aggressive Management Urged to Prevent Cardiovascular Risk Migration

March 30, 2007

NEW ORLEANS -- Cardiovascular risk is not static and intermediate risk patients may be on their way toward high risk, although that migration might be avoided or slowed by aggressive management.

ASCO PROSTATE: Survival After Radiation Plus Androgen Mirrors Healthy Men

February 27, 2007

KISSIMMEE, Fla. -- Radiation and androgen deprivation appears to bestow survival times for prostate cancer patients that are similar to the life expectancies of men of the same age who did not have cancer, researchers here reported.

ASCO PROSTATE: Imaging Not Helpful in Men With Low PSA in Biochemical Failure

February 27, 2007

KISSIMMEE, Fla. -- After definitive prostate cancer therapy, there is little value in imaging studies when patients with biochemical failure are asymptomatic and have PSA levels less than 5 ng/mL, researchers here reported.

ASCO PROSTATE: Imaging Agent Helps Pinpoint Margins of Prostate Cancers

February 26, 2007

KISSIMMEE, Fla. -- Fusion imaging with the capromab pendetide (ProstaScint) imaging agent allows for more precise placement of radioactive seeds for brachytherapy, researchers here reported.

ASCO PROSTATE: Docetaxel-Based Therapy Viewed for Refractory Prostate Cancer

February 26, 2007

KISSIMMEE, Fla. -- Docetaxel (Taxotere)-based combination therapy using is being investigated in a dozen trials for hormone refractory prostate cancer, investigators reported here.

ASCO PROSTATE: Androgen Receptor Test Predicts Risk of Prostate Cancer Metastasis

February 26, 2007

KISSIMMEE, Fla. -- A test that tallies the number of androgen receptors in a single prostate cancer cell may be an effective predictor of disease metastasis, researchers here reported.